Raymond F. Schinazi, Director, 10% Owner at Cocrystal Pharma, Inc. (COCP), bought 3,464,855 shares at $0.92 ($3.2M) on 2015-04-21, disclosed to the SEC on 2015-04-23.
Open-market purchase of $3.2M COCP by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| Filing → |
| COCP | BUY | 2016-09-06 | $4.0M | — | Filing → |
| COCP | BUY | 2016-03-17 | $3.0M | — | Filing → |